1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis)

BACKGROUND: Ceftriaxone–sulbactam–EDTA (CSE) is a novel combination being developed to treat serious infections caused by Gram-negative bacteria. In vitro molecular biology studies have shown that the addition of EDTA in the combination helps to prevent horizontal gene transfer during conjugation by...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Mohd Amin, Chaudhary, Saransh, Chaudhary, Manu, Pyasi, Anurag, Patil, N S, Girotra, Ruchi, Narang, Salil, Fatima, Nazish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253802/
http://dx.doi.org/10.1093/ofid/ofy210.1640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253802/
http://dx.doi.org/10.1093/ofid/ofy210.1640

Ejemplares similares